Assembly Biosciences, Inc. Research and Development Expense
Assembly Biosciences, Inc. (ASMB) reported Research and Development Expense of $14.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Assembly Biosciences, Inc. research and development expense for the quarter ending 2026-06-30 was $14.92M, a 7.49% decline year-over-year.
- Assembly Biosciences, Inc. research and development expense for the quarter ending 2026-03-31 was $14.90M, a 0.33% increase year-over-year.
- Assembly Biosciences, Inc. research and development expense for the quarter ending 2025-12-31 was $17.25M, a 20.80% increase year-over-year.
- Assembly Biosciences, Inc. research and development expense for the quarter ending 2025-09-30 was $16.59M, a 22.73% increase year-over-year.
- Assembly Biosciences, Inc. research and development expense for fiscal 2025 was $64.81M, a 15.88% increase from fiscal 2024.
- Assembly Biosciences, Inc. research and development expense for fiscal 2024 was $55.93M, a 14.38% increase from fiscal 2023.
- Assembly Biosciences, Inc. research and development expense for fiscal 2023 was $48.90M, a 30.12% decline from fiscal 2022.
- Assembly Biosciences, Inc. research and development expense for fiscal 2022 was $69.98M, a 2.12% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 69 month | Research and Development Expense 72 month | Research and Development Expense 75 month | Research and Development Expense 78 month | Research and Development Expense 81 month | Research and Development Expense 84 month | Research and Development Expense 87 month | Research and Development Expense 90 month | Research and Development Expense 93 month | Research and Development Expense 96 month | Research and Development Expense 99 month | Research and Development Expense 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.92M 10-Q · filed 2026-08-13 | $29.82M 10-Q · filed 2026-08-13 | $47.07M derived: sum of 3 quarters · filed 2026-08-13 | $63.65M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | $14.90M 10-Q · filed 2026-05-07 | $32.15M derived: sum of 2 quarters · filed 2026-05-07 | $48.74M derived: sum of 3 quarters · filed 2026-05-07 | $64.86M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $17.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $33.84M derived: sum of 2 quarters · filed 2026-03-19 | $49.96M derived: sum of 3 quarters · filed 2026-08-13 | $64.81M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2025-09-30 | $16.59M 10-Q · filed 2025-11-10 | $32.71M derived: sum of 2 quarters · filed 2026-08-13 | $47.56M 10-Q · filed 2025-11-10 | $61.84M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | $16.13M 10-Q · filed 2026-08-13 | $30.98M 10-Q · filed 2026-08-13 | $45.26M derived: sum of 3 quarters · filed 2026-08-13 | $58.77M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | $14.85M 10-Q · filed 2026-05-07 | $29.13M derived: sum of 2 quarters · filed 2026-05-07 | $42.65M derived: sum of 3 quarters · filed 2026-05-07 | $58.91M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | $14.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $27.80M derived: sum of 2 quarters · filed 2026-03-19 | $44.05M derived: sum of 3 quarters · filed 2026-03-19 | $55.93M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2024-09-30 | $13.52M 10-Q · filed 2025-11-10 | $29.77M derived: sum of 2 quarters · filed 2025-11-10 | $41.65M 10-Q · filed 2025-11-10 | $52.66M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||||
| 2024-06-30 | $16.26M 10-Q · filed 2025-08-06 | $28.14M 10-Q · filed 2025-08-06 | $39.14M derived: sum of 3 quarters · filed 2025-08-06 | $49.97M derived: sum of 4 quarters · filed 2025-08-06 | ||||||||||||||||
| 2024-03-31 | $11.88M 10-Q · filed 2025-05-08 | $22.89M derived: sum of 2 quarters · filed 2025-05-08 | $33.71M derived: sum of 3 quarters · filed 2025-05-08 | $46.23M derived: sum of 4 quarters · filed 2025-05-08 | ||||||||||||||||
| 2023-12-31 | $11.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $21.83M derived: sum of 2 quarters · filed 2025-03-20 | $34.35M derived: sum of 3 quarters · filed 2025-03-20 | $48.90M 10-K · filed 2025-03-20 | ||||||||||||||||
| 2023-09-30 | $10.82M 10-Q · filed 2024-11-07 | $23.35M derived: sum of 2 quarters · filed 2024-11-07 | $37.89M 10-Q · filed 2024-11-07 | $54.75M derived: sum of 4 quarters · filed 2024-11-07 | ||||||||||||||||
| 2023-06-30 | $12.52M 10-Q · filed 2024-08-08 | $27.07M 10-Q · filed 2024-08-08 | $43.92M derived: sum of 3 quarters · filed 2024-08-08 | $62.05M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||||||||
| 2023-03-31 | $14.55M 10-Q · filed 2024-05-08 | $31.40M derived: sum of 2 quarters · filed 2024-05-08 | $49.53M derived: sum of 3 quarters · filed 2024-05-08 | $67.32M derived: sum of 4 quarters · filed 2024-05-08 | ||||||||||||||||
| 2022-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $34.98M derived: sum of 2 quarters · filed 2024-03-28 | $52.77M derived: sum of 3 quarters · filed 2024-03-28 | $69.98M 10-K · filed 2024-03-28 | ||||||||||||||||
| 2022-09-30 | $18.13M 10-Q · filed 2023-11-08 | $35.92M derived: sum of 2 quarters · filed 2023-11-08 | $53.13M 10-Q · filed 2023-11-08 | $67.87M derived: sum of 4 quarters · filed 2023-11-08 | ||||||||||||||||
| 2022-06-30 | $17.79M 10-Q · filed 2023-08-09 | $35.00M 10-Q · filed 2023-08-09 | $49.74M derived: sum of 3 quarters · filed 2023-08-09 | $68.22M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||||||||
| 2022-03-31 | $17.20M 10-Q · filed 2023-05-04 | $31.95M derived: sum of 2 quarters · filed 2023-05-04 | $50.43M derived: sum of 3 quarters · filed 2023-05-04 | $67.17M derived: sum of 4 quarters · filed 2023-05-04 | ||||||||||||||||
| 2021-12-31 | $14.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $33.22M derived: sum of 2 quarters · filed 2023-03-22 | $49.97M derived: sum of 3 quarters · filed 2023-03-22 | $68.52M 10-K · filed 2023-03-22 | ||||||||||||||||
| 2021-09-30 | $18.47M 10-Q · filed 2022-11-08 | $35.22M derived: sum of 2 quarters · filed 2022-11-08 | $53.78M 10-Q · filed 2022-11-08 | $87.29M derived: sum of 4 quarters · filed 2022-11-08 | ||||||||||||||||
| 2021-06-30 | $16.75M 10-Q · filed 2022-08-09 | $35.30M 10-Q · filed 2022-08-09 | $68.81M derived: sum of 3 quarters · filed 2022-08-09 | $95.75M derived: sum of 4 quarters · filed 2022-08-09 | ||||||||||||||||
| 2021-03-31 | $18.55M 10-Q · filed 2022-05-12 | $52.06M derived: sum of 2 quarters · filed 2022-05-12 | $79.00M derived: sum of 3 quarters · filed 2022-05-12 | $102.33M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||||
| 2020-12-31 | $33.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $60.45M derived: sum of 2 quarters · filed 2022-03-11 | $83.78M derived: sum of 3 quarters · filed 2022-03-11 | $106.82M 10-K · filed 2022-03-11 | ||||||||||||||||
| 2020-09-30 | $26.94M 10-Q · filed 2021-11-04 | $50.27M derived: sum of 2 quarters · filed 2021-11-04 | $73.31M 10-Q · filed 2021-11-04 | $95.93M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||||||||
| 2020-06-30 | $23.33M 10-Q · filed 2021-08-05 | $46.37M 10-Q · filed 2021-08-05 | $68.99M derived: sum of 3 quarters · filed 2021-08-05 | $90.72M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||||||
| 2020-03-31 | $23.05M 10-Q · filed 2021-05-06 | $45.66M derived: sum of 2 quarters · filed 2021-05-06 | $67.40M derived: sum of 3 quarters · filed 2021-05-06 | $86.10M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||||||
| 2019-12-31 | $22.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $44.35M derived: sum of 2 quarters · filed 2021-02-25 | $63.05M derived: sum of 3 quarters · filed 2021-02-25 | $85.76M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2019-09-30 | $21.74M 10-Q · filed 2020-11-05 | $40.44M derived: sum of 2 quarters · filed 2020-11-05 | $63.14M 10-Q · filed 2020-11-05 | $84.39M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-06-30 | $18.70M 10-Q · filed 2020-08-05 | $41.41M 10-Q · filed 2020-08-05 | $62.66M derived: sum of 3 quarters · filed 2021-02-25 | $81.76M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-03-31 | $22.70M 10-Q · filed 2020-05-08 | $43.95M derived: sum of 2 quarters · filed 2021-02-25 | $63.06M derived: sum of 3 quarters · filed 2021-02-25 | $80.90M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2018-12-31 | $21.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $40.36M derived: sum of 2 quarters · filed 2021-02-25 | $58.20M derived: sum of 3 quarters · filed 2021-02-25 | $72.74M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2018-09-30 | $19.11M 10-Q · filed 2019-11-07 | $19.11M 10-Q · filed 2018-11-08 | $36.95M derived: sum of 2 quarters · filed 2019-11-07 | $51.49M 10-Q · filed 2019-11-07 | $51.49M 10-Q · filed 2018-11-08 | $62.09M derived: sum of 4 quarters · filed 2020-03-04 | ||||||||||||||
| 2018-06-30 | $17.84M 10-Q · filed 2019-08-05 | $17.84M 10-Q · filed 2018-08-08 | $32.38M 10-Q · filed 2019-08-05 | $32.38M 10-Q · filed 2018-08-08 | $42.98M derived: sum of 3 quarters · filed 2020-03-04 | $53.91M derived: sum of 4 quarters · filed 2020-03-04 | ||||||||||||||
| 2018-03-31 | $14.54M 10-Q · filed 2019-05-09 | $14.54M 10-Q · filed 2018-05-07 | $25.14M derived: sum of 2 quarters · filed 2020-03-04 | $36.07M derived: sum of 3 quarters · filed 2020-03-04 | $48.19M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2017-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $21.53M derived: sum of 2 quarters · filed 2020-03-04 | $33.65M derived: sum of 3 quarters · filed 2020-03-04 | $44.23M 10-K · filed 2020-03-04 | $44.23M 10-K · filed 2018-03-08 | |||||||||||||||
| 2017-09-30 | $10.93M 10-Q · filed 2018-11-08 | $23.05M derived: sum of 2 quarters · filed 2018-11-08 | $33.63M 10-Q · filed 2018-11-08 | $42.25M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||||||
| 2017-06-30 | $12.13M 10-Q · filed 2018-08-08 | $22.70M 10-Q · filed 2018-08-08 | $31.32M derived: sum of 3 quarters · filed 2019-02-28 | $40.15M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||||||
| 2017-03-31 | $10.57M 10-Q · filed 2018-05-07 | $19.20M derived: sum of 2 quarters · filed 2019-02-28 | $28.03M derived: sum of 3 quarters · filed 2019-02-28 | $35.55M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||||||
| 2016-12-31 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $17.46M derived: sum of 2 quarters · filed 2019-02-28 | $24.97M derived: sum of 3 quarters · filed 2019-02-28 | $33.09M 10-K · filed 2019-02-28 | $33.09M 10-K · filed 2017-03-02 | |||||||||||||||
| 2016-09-30 | $8.83M 10-Q · filed 2017-11-01 | $16.35M derived: sum of 2 quarters · filed 2017-11-01 | $24.47M 10-Q · filed 2017-11-01 | $29.70M derived: sum of 4 quarters · filed 2018-03-08 | ||||||||||||||||
| 2016-06-30 | $7.52M 10-Q · filed 2017-08-09 | $15.64M 10-Q · filed 2017-08-09 | $20.86M derived: sum of 3 quarters · filed 2018-03-08 | $25.49M derived: sum of 4 quarters · filed 2018-03-08 | ||||||||||||||||
| 2016-03-31 | $8.12M 10-Q · filed 2017-05-08 | $13.34M derived: sum of 2 quarters · filed 2018-03-08 | $17.97M derived: sum of 3 quarters · filed 2018-03-08 | $22.64M derived: sum of 4 quarters · filed 2018-03-08 | ||||||||||||||||
| 2015-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $9.86M derived: sum of 2 quarters · filed 2018-03-08 | $14.52M derived: sum of 3 quarters · filed 2018-03-08 | $18.36M 10-K · filed 2018-03-08 | ||||||||||||||||
| 2015-09-30 | $4.63M 10-Q · filed 2016-11-09 | $9.30M derived: sum of 2 quarters · filed 2016-11-09 | $13.13M 10-Q · filed 2016-11-09 | $16.11M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||||||||
| 2015-06-30 | $4.67M 10-Q · filed 2016-08-09 | $8.50M 10-Q · filed 2016-08-09 | $11.48M derived: sum of 3 quarters · filed 2017-03-02 | $15.15M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||||||||
| 2015-03-31 | $3.83M 10-Q · filed 2016-05-10 | $6.81M derived: sum of 2 quarters · filed 2017-03-02 | $10.48M derived: sum of 3 quarters · filed 2017-03-02 | $11.58M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||||||||
| 2014-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $6.65M derived: sum of 2 quarters · filed 2017-03-02 | $7.74M derived: sum of 3 quarters · filed 2017-03-02 | $10.72M 10-K · filed 2017-03-02 | ||||||||||||||||
| 2014-09-30 | $3.67M 10-Q · filed 2015-11-09 | $4.77M derived: sum of 2 quarters · filed 2015-11-09 | $7.74M 10-Q · filed 2015-11-09 | $12.90M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2014-06-30 | $1.10M 10-Q · filed 2015-08-13 | $4.07M 10-Q · filed 2015-08-13 | $9.23M derived: sum of 3 quarters · filed 2015-08-13 | $12.98M derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||||||
| 2014-03-31 | $2.97M 10-Q · filed 2015-05-08 | $8.13M derived: sum of 2 quarters · filed 2015-05-08 | $11.89M derived: sum of 3 quarters · filed 2015-05-08 | $15.39M derived: sum of 4 quarters · filed 2015-05-08 | $77.05M 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $8.91M derived: sum of 2 quarters · filed 2015-03-16 | $12.42M derived: sum of 3 quarters · filed 2015-03-16 | $15.03M 10-K · filed 2015-03-16 | $74.07M 10-K · filed 2014-03-31 | |||||||||||||||
| 2013-09-30 | $3.75M 10-Q · filed 2014-11-17 | $7.26M derived: sum of 2 quarters · filed 2014-11-17 | $9.87M 10-Q · filed 2014-11-17 | $12.61M derived: sum of 4 quarters · filed 2014-11-17 | $68.91M 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $3.51M 10-Q · filed 2014-08-14 | $6.12M 10-Q · filed 2014-08-14 | $8.86M derived: sum of 3 quarters · filed 2014-08-14 | $13.05M derived: sum of 4 quarters · filed 2014-08-14 | $65.16M 10-Q · filed 2013-08-09 | |||||||||||||||
| 2013-03-31 | $2.61M 10-Q · filed 2014-05-14 | $5.35M derived: sum of 2 quarters · filed 2014-05-14 | $9.54M derived: sum of 3 quarters · filed 2014-05-14 | $15.70M derived: sum of 4 quarters · filed 2014-05-14 | $61.65M 10-Q · filed 2013-05-10 | |||||||||||||||
| 2012-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $6.93M derived: sum of 2 quarters · filed 2014-03-31 | $13.09M derived: sum of 3 quarters · filed 2014-03-31 | $19.51M 10-K · filed 2014-03-31 | $59.04M 10-K · filed 2013-03-18 | |||||||||||||||
| 2012-09-30 | $4.19M 10-Q · filed 2013-11-12 | $10.35M derived: sum of 2 quarters · filed 2013-11-12 | $16.77M 10-Q · filed 2013-11-12 | $34.31M derived: sum of 4 quarters · filed 2013-11-12 | $56.30M 10-Q · filed 2012-11-13 | |||||||||||||||
| 2012-06-30 | $6.16M 10-Q · filed 2013-08-09 | $12.58M 10-Q · filed 2013-08-09 | $30.12M derived: sum of 3 quarters · filed 2013-08-09 | $33.79M derived: sum of 4 quarters · filed 2013-08-09 | $52.11M 10-Q · filed 2012-08-09 | |||||||||||||||
| 2012-03-31 | $6.42M 10-Q · filed 2013-05-10 | $23.96M derived: sum of 2 quarters · filed 2013-05-10 | $27.63M derived: sum of 3 quarters · filed 2013-05-10 | $30.73M derived: sum of 4 quarters · filed 2013-05-10 | $45.95M 10-Q · filed 2012-05-09 | |||||||||||||||
| 2011-12-31 | $17.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $21.21M derived: sum of 2 quarters · filed 2013-03-18 | $24.31M derived: sum of 3 quarters · filed 2013-03-18 | $25.28M 10-K · filed 2013-03-18 | $39.53M 10-K · filed 2012-03-14 | |||||||||||||||
| 2011-09-30 | $3.67M 10-Q · filed 2012-11-13 | $6.77M derived: sum of 2 quarters · filed 2012-11-13 | $7.74M 10-Q · filed 2012-11-13 | $8.46M derived: sum of 4 quarters · filed 2013-03-18 | $21.99M 10-Q/A · filed 2011-11-18 | |||||||||||||||
| 2011-06-30 | $3.10M 10-Q · filed 2012-08-09 | $4.07M 10-Q · filed 2012-08-09 | $4.79M derived: sum of 3 quarters · filed 2013-03-18 | $4.99M derived: sum of 4 quarters · filed 2013-03-18 | $18.32M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $970.76K 10-Q · filed 2012-05-09 | $1.69M derived: sum of 2 quarters · filed 2013-03-18 | $1.89M derived: sum of 3 quarters · filed 2013-03-18 | $2.41M derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||||||
| 2010-12-31 | $722.55K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $915.74K derived: sum of 2 quarters · filed 2013-03-18 | $1.44M derived: sum of 3 quarters · filed 2013-03-18 | $1.85M 10-K · filed 2013-03-18 | ||||||||||||||||
| 2010-09-30 | $193.18K 10-Q/A · filed 2011-11-18 | $714.37K derived: sum of 2 quarters · filed 2011-11-18 | $1.13M 10-Q/A · filed 2011-11-18 | |||||||||||||||||
| 2010-06-30 | $521.18K 10-Q · filed 2011-08-15 | $934.93K 10-Q · filed 2011-08-15 | ||||||||||||||||||
| 2009-12-31 | $2.94M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |